Company Analysis
Sign in

Aethlon Medical, Inc. (AEMD)

Nasdaq: AEMD · Surgical & Medical Instruments & Apparatus · San Diego, CA · filing with the SEC since 1997
Full chart Alerts Compare
Grade3.7
◀ Past 1.7● Present 4.1▶ Future 5.2
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Aethlon Medical, Inc.’s names, not what it holds today.

Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
23
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'09'11'12'13'14'15'16'17'18'19'20'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Aethlon Medical, Inc. its own name
US, as the owner printed on each patent
6 granted
10 published
Aethlon Medical, Inc. its own name
named as the applicant on its applications, in US
0 granted
13 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 9, 202512,409,260Devices and methods for treating a coronavirus infection and symptoms thereofMedical technologyAethlon Medical, Inc.
Jul 17, 201810,022,483Method for removal of viruses from blood by lectin affinity hemodialysisMedical technologyAethlon Medical, Inc.
Jul 18, 20179,707,333Extracorporeal removal of microvesicular particlesMedical technologyAethlon Medical, Inc.
Jun 14, 20169,364,601Extracorporeal removal of microvesicular particlesMedical technologyAethlon Medical, Inc.
Oct 16, 20128,288,172Extracorporeal removal of microvesicular particlesMedical technologyAethlon Medical, Inc.
Jun 5, 20077,226,429Method for removal of viruses from blood by lectin affinity hemodialysisMedical technologyAethlon Medical, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 5, 20242024/0399042DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOFChemical engineeringAethlon Medical, Inc.
May 25, 20232023/0158222DEVICES AND METHODS FOR TREATING A CORONAVIRUS INFECTION AND SYMPTOMS THEREOFMedical technologyAethlon Medical, Inc. · patent 12,409,260 granted from it
Dec 2, 20212021/0369933METHOD FOR REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSISMedical technologyAethlon Medical, Inc.
Feb 25, 20212021/0052866MULTIPLEX CEREBROSPINAL FLUID PROCESSING SYSTEMMedical technologyAethlon Medical, Inc.
May 28, 20202020/0166514METHODS AND COMPOSITIONS FOR QUANTIFYING EXOSOMESAnalysis of biological materialsAethlon Medical, Inc.
Apr 2, 20202020/0103414AFFINITY CAPTURE OF CIRCULATING BIOMARKERSAnalysis of biological materialsAethlon Medical, Inc.
Jun 13, 20192019/0175812METHOD FOR REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSISMedical technologyAethlon Medical, Inc.
Aug 16, 20182018/0231569AFFINITY CAPTURE OF CIRCULATING BIOMARKERSAnalysis of biological materialsAethlon Medical, Inc.
Feb 22, 20182018/0050148METHODS FOR DELIVERING REGIONAL CITRATE ANTICOAGULATION (RCA) DURING EXTRACORPOREAL BLOOD TREATMENTSMedical technologyAethlon Medical, Inc.
Jun 9, 20162016/0161502AFFINITY CAPTURE OF CIRCULATING BIOMARKERSAnalysis of biological materialsAethlon Medical, Inc.
What it applied for, 2024 to 2025: Chemical engineering 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton AEMD · research, not advice